je.st
news
Home
› Accelerate Development Of Cancer Immunotherapy (iOnc) Drugs With New PathHunter Checkpoint Assays From DiscoveRx
Accelerate Development Of Cancer Immunotherapy (iOnc) Drugs With New PathHunter Checkpoint Assays From DiscoveRx
2016-02-03 03:52:40| drugdiscoveryonline News Articles
DiscoveRx Corporation, the leading supplier of innovative cell-based assays and services for drug discovery and development, announced today the expansion of its PathHunter cell-based assays portfolio with the release of PathHunter Checkpoint Assays
Tags: development
cancer
drugs
accelerate
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||